HRP20200472T1 - Liječenje alopecije areate - Google Patents
Liječenje alopecije areate Download PDFInfo
- Publication number
- HRP20200472T1 HRP20200472T1 HRP20200472TT HRP20200472T HRP20200472T1 HR P20200472 T1 HRP20200472 T1 HR P20200472T1 HR P20200472T T HRP20200472T T HR P20200472TT HR P20200472 T HRP20200472 T HR P20200472T HR P20200472 T1 HRP20200472 T1 HR P20200472T1
- Authority
- HR
- Croatia
- Prior art keywords
- compound
- treatment
- alopecia areata
- therapeutic
- concentration
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15186644 | 2015-09-24 | ||
| JP2015190849A JP2017066061A (ja) | 2015-09-29 | 2015-09-29 | 円形脱毛症治療剤 |
| EP16775134.6A EP3352734B1 (en) | 2015-09-24 | 2016-09-22 | Treatment of alopecia areata |
| PCT/EP2016/072531 WO2017050891A1 (en) | 2015-09-24 | 2016-09-22 | Treatment of alopecia areata |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20200472T1 true HRP20200472T1 (hr) | 2020-09-18 |
Family
ID=57047187
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20200472TT HRP20200472T1 (hr) | 2015-09-24 | 2016-09-22 | Liječenje alopecije areate |
Country Status (27)
| Country | Link |
|---|---|
| US (3) | US20180263986A1 (https=) |
| EP (1) | EP3352734B1 (https=) |
| JP (1) | JP6776345B2 (https=) |
| KR (1) | KR102728341B1 (https=) |
| CN (1) | CN108135834B (https=) |
| AU (3) | AU2016325388A1 (https=) |
| BR (1) | BR112018005771B1 (https=) |
| CA (1) | CA2998972A1 (https=) |
| CY (1) | CY1122837T1 (https=) |
| DK (1) | DK3352734T3 (https=) |
| ES (1) | ES2779762T3 (https=) |
| HR (1) | HRP20200472T1 (https=) |
| HU (1) | HUE049052T2 (https=) |
| IL (3) | IL298520A (https=) |
| LT (1) | LT3352734T (https=) |
| MX (1) | MX375024B (https=) |
| MY (1) | MY196541A (https=) |
| PL (1) | PL3352734T3 (https=) |
| PT (1) | PT3352734T (https=) |
| RS (1) | RS60365B1 (https=) |
| RU (1) | RU2754997C2 (https=) |
| SG (1) | SG10202111361TA (https=) |
| SI (1) | SI3352734T1 (https=) |
| TW (1) | TWI720022B (https=) |
| UA (1) | UA124192C2 (https=) |
| WO (1) | WO2017050891A1 (https=) |
| ZA (1) | ZA201801722B (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4674401A3 (en) * | 2019-12-27 | 2026-02-25 | Rohto Pharmaceutical Co., Ltd | Container accommodating an aqueous ophthalmic composition comprising delgocitinib |
| WO2023029943A1 (zh) * | 2021-09-03 | 2023-03-09 | 星药科技(北京)有限公司 | 一种芳杂环化合物及其制备方法和用途 |
| JP2025514747A (ja) | 2022-04-20 | 2025-05-09 | レオ ファーマ アクティーゼルスカブ | 前頭部線維性脱毛症の治療 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI466885B (zh) * | 2009-07-31 | 2015-01-01 | Japan Tobacco Inc | 含氮螺環化合物及其醫藥用途 |
| US8637569B2 (en) * | 2009-10-22 | 2014-01-28 | Api Genesis, Llc | Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compounds |
| US20140343034A1 (en) * | 2013-04-25 | 2014-11-20 | Japan Tobacco Inc. | Skin barrier function improving agent |
| KR102306276B1 (ko) * | 2013-10-21 | 2021-09-30 | 니뽄 다바코 산교 가부시키가이샤 | 안질환의 치료제 또는 예방제 |
-
2016
- 2016-09-22 KR KR1020187010871A patent/KR102728341B1/ko active Active
- 2016-09-22 HU HUE16775134A patent/HUE049052T2/hu unknown
- 2016-09-22 WO PCT/EP2016/072531 patent/WO2017050891A1/en not_active Ceased
- 2016-09-22 US US15/762,188 patent/US20180263986A1/en not_active Abandoned
- 2016-09-22 RU RU2018114922A patent/RU2754997C2/ru active
- 2016-09-22 HR HRP20200472TT patent/HRP20200472T1/hr unknown
- 2016-09-22 SG SG10202111361TA patent/SG10202111361TA/en unknown
- 2016-09-22 PL PL16775134T patent/PL3352734T3/pl unknown
- 2016-09-22 MY MYPI2018701140A patent/MY196541A/en unknown
- 2016-09-22 IL IL298520A patent/IL298520A/en unknown
- 2016-09-22 ES ES16775134T patent/ES2779762T3/es active Active
- 2016-09-22 UA UAA201804378A patent/UA124192C2/uk unknown
- 2016-09-22 IL IL312861A patent/IL312861A/en unknown
- 2016-09-22 DK DK16775134.6T patent/DK3352734T3/da active
- 2016-09-22 EP EP16775134.6A patent/EP3352734B1/en active Active
- 2016-09-22 CA CA2998972A patent/CA2998972A1/en active Pending
- 2016-09-22 AU AU2016325388A patent/AU2016325388A1/en not_active Abandoned
- 2016-09-22 CN CN201680054554.7A patent/CN108135834B/zh active Active
- 2016-09-22 MX MX2018003332A patent/MX375024B/es active IP Right Grant
- 2016-09-22 BR BR112018005771-1A patent/BR112018005771B1/pt active IP Right Grant
- 2016-09-22 JP JP2018515582A patent/JP6776345B2/ja active Active
- 2016-09-22 SI SI201630694T patent/SI3352734T1/sl unknown
- 2016-09-22 LT LTEP16775134.6T patent/LT3352734T/lt unknown
- 2016-09-22 PT PT167751346T patent/PT3352734T/pt unknown
- 2016-09-22 RS RS20200322A patent/RS60365B1/sr unknown
- 2016-09-23 TW TW105130927A patent/TWI720022B/zh active
-
2018
- 2018-03-06 IL IL257918A patent/IL257918A/en unknown
- 2018-03-13 ZA ZA2018/01722A patent/ZA201801722B/en unknown
-
2020
- 2020-03-20 CY CY20201100268T patent/CY1122837T1/el unknown
-
2021
- 2021-04-13 US US17/228,831 patent/US20220088020A1/en not_active Abandoned
-
2022
- 2022-04-14 AU AU2022202508A patent/AU2022202508A1/en not_active Abandoned
-
2024
- 2024-01-05 US US18/405,453 patent/US20240398809A1/en not_active Abandoned
- 2024-07-09 AU AU2024204716A patent/AU2024204716A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2918938C (en) | Substituted aminopyrimidine compounds and methods of use | |
| MY193514A (en) | Solid forms and formulations of (s)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1, 5-a]pyrazin-1-yl)-n-(pyridin-2-yl)benzamide | |
| EA201590371A1 (ru) | 1,4-дизамещенные аналоги пиридазина и способы лечения связанных с дефицитом smn состояний | |
| WO2012034055A3 (en) | Compounds as c-met kinase inhibitors | |
| MX379425B (es) | 7-bencil-4-(2-metilbencilo) -2,4,6,7,8,9-hexahidroimidazo [1,2-a] pirido [3,4-e] pirimidin-5 (1h) -ona, análogos y sales del mismo y su uso en terapia. | |
| MA39092A1 (fr) | Pyrrolo[2,3-d]pyrimidinyle, pyrrolo[2,3-b]pyrazinyle et pyrollo[2,3-d]pyridinyle acrylamides | |
| GEP201706774B (en) | Heterocyclyl compounds | |
| EA201300556A1 (ru) | Аминоспиртзамещенные производные 2,3-дигидроимидазо[1,2-с] хиназолина, пригодные для лечения гиперпролиферативных нарушений и заболеваний, связанных с ангиогенезом | |
| EA201070841A1 (ru) | НОВЫЕ ПИРАЗОЛО[3,4-d]ПИРИМИДИНОВЫЕ ПРОИЗВОДНЫЕ В КАЧЕСТВЕ ПРОТИВОРАКОВЫХ ЛЕКАРСТВЕННЫХ СРЕДСТВ | |
| PH12014502366B1 (en) | Injectable formulation | |
| MX345238B (es) | (aralquilamino y heteroarilalquilamino alfa-substituidos)pirimidin ilo y 1,3,5-triazinilbenzimidazoles, composiciones farmacéuticas que los contienen, y estos compuestos para su uso en el tratamiento de enfermedades proliferativas. | |
| EA201491674A1 (ru) | Новые фармацевтические композиции | |
| MX2014009850A (es) | Spiro [2.4] heptanos para aplicaciones relacionadas con el tratamiento de infecciones de flaviviridae. | |
| BR112015020823A8 (pt) | 1-hidróxi-benzooxaboróis como agentes antiparasíticos, seus usos, e formulação". | |
| HRP20211653T1 (hr) | 7-benzil-4-(2-metilbenzil)-2,4,6,7,8,9-heksahidroimidazo[1,2-a]pirido[3,4-e]pirimidin-5(1h)-on, njegove soli i postupci korištenja istih u kombiniranoj terapiji | |
| HRP20200472T1 (hr) | Liječenje alopecije areate | |
| HRP20231448T1 (hr) | Primjena delgocitiniba za liječenje kroničnog ekcema ruku | |
| WO2014014794A3 (en) | Mineralocorticoid receptor antagonists | |
| HRP20151340T1 (hr) | Derivati tieno[2,3-d] pirimidina i njihova primjena u lijeäśenju aritmije | |
| JP2018528238A5 (https=) | ||
| MA53509A (fr) | Agent thérapeutique contenant un composé pyrazolo[3,4-d]pyrimidine comme ingrédient actif | |
| NZ740690B2 (en) | Treatment of alopecia areata | |
| JP2012530709A5 (https=) | ||
| EA201500366A1 (ru) | Применение 1-адамантилетилокси-3-морфолино-2-пропанола или его фармацевтически приемлемых солей в фармацевтических композициях в качестве нейроретинопротектора | |
| RU2013127881A (ru) | Применение фармацевтической композиции на основе соли четвертичного фосфония и замещенного динитробензофуроксана для лечения пироплазмоза у собак и способ лечения |